Organizing Committee –  Dr. Robert Naviaux, Dr. Robert Lustig and Dr. Sundeep Dugar.

• Robert Lustig, MD, MSL (Opening Remarks)
  Professor Emeritus of Pediatrics, Division of Endocrinology at the University of California at San Francisco. He also serves on the Scientific Advisory Board of Blue Oak Nutraceuticals, Inc; author of several best-selling books including Fat Chance, Hacking of the American Mind, and Metabolical.
  
  
• Andrew Dillin, Ph.D.
  Professor, University of California at Berkeley, Departments of Molecular and Cell Biology, Immunology and Molecular Medicine. Howard Hughes Medical Investigator and the Thomas and Stacey Siebel Distinguished Chair in Stem Cell Research at the Department of Molecular and Cell Biology.
  
  
• Phillip Dumesic, MD, Ph.D.
  Assistant Professor in the Diabetes Center at University of California, San Francisco. His research has been supported by the Damon Runyon Cancer Research Foundation and the National Institutes of Health.
  
  
• Elissa Epel, Ph.D.
  Professor and Vice Chair in the Department of Psychiatry and Behavioral Sciences, at University of California, San Francisco. Director of the Aging, Metabolism, and Emotions Center, Associate Director of the Center for Health and Community and the NIDDK UCSF NORC, member of the National Academy of Medicine, and past President of the Academy of Behavioral Medicine Research and Co-Chair of the Mind and Life Institute Steering Council.
  
  

• Mark Mattson, Ph.D.
  

  Adjunct Professor of Neuroscience, John Hopkins University School of Medicine and Former Chief of the Laboratory of Neurosciences at the National Institute on Aging, National Institutes of Health. He is the author of the books The Intermittent Fasting Revolution and Sculptor and Destroyer.

   

• Robert Naviaux, MD, Ph.D.
  Founder of the UCSD Mitochondrial and Metabolic Disease Center (MMDC). He discovered the cause of Alpers syndrome, and part of the team that reported the first mitochondrial DNA mutation to cause genetic forms of autism.
  
  

• Mark Tarnopolsky, MD, Ph.D.
  McMaster Children’s Hospital / Hamilton Health Sciences Foundation Chair in Neuromuscular Disorders, Professor of Pediatrics and Medicine, Division Head of Neuromuscular and Neurometabolic Disorders, McMaster Children’s Hospital, Canada, CEO and CSO, Exerkine Corporation.

   

• Sundeep Dugar, Ph.D. (Closing Remarks)
  Pharma drug discovery expert with over 35 years of experience in small-molecule drug discovery and development in oncology, inflammation, the central nervous system, cardiovascular and metabolic disorders. Co-inventor of best-selling drugs Zetia® (ezetimibe) and Vytorin® (ezetimibe/simvastatin).